SLA congratulates Roslin Cells on their recent success with TSB funding

Released: Thursday 23rd August 2012

 SLA is delighted to see Roslin Cells secure over £125 K in funding from the Biocatalyst Feasibility Competition. Roslin Cells will use this to  

improve the clinical utility of umbilical cord blood donations by Ex-Vivo Expansion using Mesenchymal Stromal Cells.

For further details please contact

View all News